Effectiveness of Combined schema-therapy and cognitive behavioral therapy in Borderline Personality Disorder; Toxoplasmosis
This study was withdrawn in Czechia. It is testing Combined schema-therapy and cognitive behavioral therapy for Borderline Personality Disorder; Toxoplasmosis.
Personality disorders, Borderline personality, ...BehavioralOver 18 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether cognitive behavioural therapy may be useful for adults experiencing personality disorders.
What would participation involve?
Participants may take part in cognitive behavioural therapy, attend study visits with the research team. The registry lists locations in Czechia.
Who is it mainly for?
This study appears to be mainly for adults with personality disorders.
What should you check before joining?
Ask about how many sessions are required and who delivers them, whether there is a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: January 1, 2021
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
Marie Ociskova
Sponsor type
Unknown or unclear
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, Medication / drug
Study phase
Not clearly listed
Locations
Czechia
Age range
Over 18 Years
Official registry ID
NCT03932656
Official title
Latent Toxoplasmosis in Females With Borderline Personality Disorder - Occurrence, Clinical Features, and Impact on Effectiveness of Combined Pharmacotherapeutic and Psychotherapeutic Treatment
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT03932656. We help you review the study, but cannot decide medical eligibility.
Recruitment & locations
Withdrawn
Olomouc, Czechia · Czechia
Registry details
Registry conditions (original wording)
Borderline Personality Disorder; Toxoplasmosis
FAQ
Questions about this study
Who is behind this study?
The study sponsor is Marie Ociskova.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
This study is completed. It focuses on personality disorders and currently lists study information in Czech Republic, Germany, Poland, Slovakia, and the United Kingdom.
